CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 79 filers reported holding MAXCYTE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$744,033
-32.0%
238,4720.0%0.00%
Q2 2023$1,094,586
-7.3%
238,472
-0.1%
0.00%
Q1 2023$1,181,372
-7.2%
238,661
+2.4%
0.00%
Q4 2022$1,272,972
-14.9%
233,145
+1.4%
0.00%
-100.0%
Q3 2022$1,495,000
+65.2%
229,969
+20.3%
0.00%
Q2 2022$905,000
-41.9%
191,172
-14.2%
0.00%
Q1 2022$1,558,000
-26.4%
222,869
+7.2%
0.00%
-100.0%
Q4 2021$2,118,000
+404.3%
207,822
+505.2%
0.00%
Q3 2021$420,00034,3370.00%
Other shareholders
MAXCYTE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders